시장보고서
상품코드
1975017

초자체 탐포네이드 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

Global Vitreous Tamponades Market Size, Share, Trends & Growth Analysis Report 2026-2034

발행일: | 리서치사: 구분자 Value Market Research | 페이지 정보: 영문 153 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

초자체 탐포네이드 시장 규모는 2025년 7,612만 달러에서 2034년에는 1억 797만 달러에 달할 것으로 예측되고 있으며, 2026-2034년에 CAGR 3.96%로 성장할 전망입니다.

세계 유리체 탐폰나데 시장은 망막 질환 및 안과 관련 질환의 발생률 증가로 인해 확대되고 있습니다. 세계 인구의 고령화와 당뇨병성 망막증 환자 증가가 첨단 안과 수술에 대한 수요를 견인하고 있습니다. 유리체 망막 수술의 기술적 발전은 치료 결과를 향상시키고 시장 성장을 지원하고 있습니다. 조기 진단과 수술적 개입에 대한 인식이 높아진 것도 채용 확대에 기여하고 있습니다.

주요 성장 요인으로는 실리콘 오일 및 가스 기반 탐포나데 제품의 발전이 꼽힙니다. 전문 안과 클리닉과 숙련된 외과 의사 증가로 환자의 치료 접근성이 향상되고 있습니다. 의료비 지출 증가와 안과 수술에 대한 보험 적용 범위 확대가 시장 확대를 지원하고 있습니다. 제품의 안전과 성능 향상에 초점을 맞춘 연구 활동은 업계의 발전을 강화하고 있습니다.

향후 지속적인 기술 혁신과 차세대 생분해성 탐폰나데의 도입으로 시장은 더 많은 혜택을 받을 것으로 예측됩니다. 개발도상국의 의료 인프라 확충은 새로운 성장 기회를 창출합니다. 고령화에 따른 망막 질환의 유병률이 증가함에 따라 효과적인 수술적 치료법에 대한 수요는 지속적으로 증가할 것이며, 장기적인 성장 전망은 견고할 것으로 보입니다.

목차

제1장 서론

제2장 개요

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 초자체 탐포네이드 시장 : 제품 유형별

제5장 세계의 초자체 탐포네이드 시장 : 용도별

제6장 세계의 초자체 탐포네이드 시장 : 최종사용자별

제7장 세계의 초자체 탐포네이드 시장 : 지역별

제8장 경쟁 구도

제9장 기업 개요

KSA 26.04.01

The Vitreous Tamponades Market size is expected to reach USD 107.97 Million in 2034 from USD 76.12 Million (2025) growing at a CAGR of 3.96% during 2026-2034.

The Global Vitreous Tamponades Market is expanding due to the rising incidence of retinal disorders and eye-related conditions. An aging global population and increasing cases of diabetic retinopathy are driving the demand for advanced ophthalmic procedures. Technological improvements in vitreoretinal surgeries have enhanced treatment outcomes, supporting market growth. Greater awareness about early diagnosis and surgical interventions is also contributing to increasing adoption.

Major growth drivers include advancements in silicone oils and gas-based tamponade products. The growing number of specialized ophthalmic clinics and skilled surgeons is improving patient access to treatment. Increased healthcare spending and insurance coverage for eye surgeries are further supporting market expansion. Research activities focused on improving product safety and performance are strengthening industry development.

In the future, the market is expected to benefit from ongoing innovation and the introduction of next-generation biodegradable tamponades. Expanding healthcare infrastructure in developing countries will create new growth opportunities. As retinal diseases become more common with aging populations, demand for effective surgical solutions will continue to rise, ensuring positive long-term growth prospects.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

  • Gaseous Tamponades
  • Liquid Tamponades
  • Silicone Oil
  • Perfluoroethane
  • Others

By Application

  • Retinal Detachment
  • Macular Hole
  • Endophthalmitis
  • Intraocular Tumors
  • Vitreous Hemorrhage
  • Others

By End User

  • Hospitals
  • Ophthalmology Clinics
  • Ambulatory Surgery Centers
  • Others

COMPANIES PROFILED

  • Alcon Inc, Bausch Lomb Incorporated, Novartis AG, Dutch Ophthalmic Research Center, Carl Zeiss Meditec AG, FCI Ophthalmics, Rayner Intraocular Lenses Limited, Arcadophtha, ALCHIMIA Srl, MedOne Surgical Inc, Tamponades Retinal TRB Chemedica AG, Endo Optiks Inc, FluoronGmbH, Refined Chemicals Pharmaceutical Company RCP, Guangzhou Vesber Biotechnology Co Ltd
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL VITREOUS TAMPONADES MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. Gaseous Tamponades Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Liquid Tamponades Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Silicone Oil Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Perfluoroethane Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL VITREOUS TAMPONADES MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Retinal Detachment Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Macular Hole Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Endophthalmitis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Intraocular Tumors Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Vitreous Hemorrhage Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL VITREOUS TAMPONADES MARKET: BY END USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Ophthalmology Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Ambulatory Surgery Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL VITREOUS TAMPONADES MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product Type
    • 7.2.2 By Application
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product Type
    • 7.3.2 By Application
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product Type
    • 7.4.2 By Application
    • 7.4.3 By End User
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product Type
    • 7.5.2 By Application
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product Type
    • 7.6.2 By Application
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL VITREOUS TAMPONADES INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Alcon Inc
    • 9.2.2 Bausch & Lomb Incorporated
    • 9.2.3 Novartis AG
    • 9.2.4 Dutch Ophthalmic Research Center
    • 9.2.5 Carl Zeiss Meditec AG
    • 9.2.6 FCI Ophthalmics
    • 9.2.7 Rayner Intraocular Lenses Limited
    • 9.2.8 Arcadophtha
    • 9.2.9 AL.CHI.MI.A Srl
    • 9.2.10 MedOne Surgical Inc
    • 9.2.11 Tamponades Retinal (TRB) Chemedica AG
    • 9.2.12 Endo Optiks Inc
    • 9.2.13 FluoronGmbH
    • 9.2.14 Refined Chemicals Pharmaceutical Company (RCP)
    • 9.2.15 Guangzhou Vesber Biotechnology Co. Ltd
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제